- Home
- CTLP vs FTRE Comparison
CTLP vs FTRE Comparison
Compare CTLP & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTLP
- FTRE
- Stock Information
- Founded
- CTLP 1992
- FTRE 1996
- Country
- CTLP United States
- FTRE United States
- Employees
- CTLP N/A
- FTRE N/A
- Industry
- CTLP EDP Services
- FTRE Medical Specialities
- Sector
- CTLP Technology
- FTRE Health Care
- Exchange
- CTLP Nasdaq
- FTRE Nasdaq
- Market Cap
- CTLP 574.8M
- FTRE 483.5M
- IPO Year
- CTLP N/A
- FTRE N/A
- Fundamental
- Price
- CTLP $7.88
- FTRE $5.92
- Analyst Decision
- CTLP Strong Buy
- FTRE Hold
- Analyst Count
- CTLP 4
- FTRE 11
- Target Price
- CTLP $12.50
- FTRE $18.00
- AVG Volume (30 Days)
- CTLP 463.7K
- FTRE 2.8M
- Earning Date
- CTLP 05-08-2025
- FTRE 05-12-2025
- Dividend Yield
- CTLP N/A
- FTRE N/A
- EPS Growth
- CTLP N/A
- FTRE N/A
- EPS
- CTLP 0.19
- FTRE N/A
- Revenue
- CTLP $285,112,000.00
- FTRE $2,696,400,000.00
- Revenue This Year
- CTLP $18.00
- FTRE N/A
- Revenue Next Year
- CTLP $15.55
- FTRE $3.38
- P/E Ratio
- CTLP $41.38
- FTRE N/A
- Revenue Growth
- CTLP 12.88
- FTRE N/A
- 52 Week Low
- CTLP $5.75
- FTRE $4.77
- 52 Week High
- CTLP $11.36
- FTRE $38.04
- Technical
- Relative Strength Index (RSI)
- CTLP 50.69
- FTRE 38.99
- Support Level
- CTLP $7.24
- FTRE $4.82
- Resistance Level
- CTLP $7.86
- FTRE $6.08
- Average True Range (ATR)
- CTLP 0.39
- FTRE 0.63
- MACD
- CTLP 0.08
- FTRE 0.26
- Stochastic Oscillator
- CTLP 87.00
- FTRE 60.53
About CTLP Cantaloupe Inc.
Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.